2026 Ebola outbreak (DR Congo)

As of 18 August 2026, WHO regional data reports 2,378 deaths from 5,021 confirmed cases in the ongoing Bundibugyo Ebola outbreak in DRC. The week ending 9 August was the worst on record, with 579 confirmed cases and 304 deaths in a single week. The case fatality rate among confirmed cases is approximately 47%. Uganda's linked outbreak was declared over on 28 July 2026 after 20 confirmed cases and 2 deaths. The DRC outbreak, now spanning five provinces, is the second-largest Ebola outbreak ever recorded globally, ahead of the 2018–2020 DRC epidemic (3,317 confirmed). There is still no approved treatment or vaccine for the rare Bundibugyo strain. Treat any figure as provisional; WHO updates counts as investigations progress. Sources: WHO, Al Jazeera, MapPR, ECDC (18 Aug 2026).

Yes. An active Ebola outbreak is ongoing in the DRC, declared a Public Health Emergency of International Concern by the WHO on 16 May 2026. As of 18 August 2026, WHO reports 2,378 deaths from 5,021 confirmed cases across five provinces. Uganda's linked outbreak was declared over on 28 July 2026. The DRC outbreak is now the second-largest Ebola outbreak in history, ahead of the 2018–2020 DRC epidemic. The Bundibugyo strain responsible has no approved treatment or vaccine. Sources: WHO, ECDC, Al Jazeera (18 Aug 2026).

Yes. Ebola has never gone away, it resurfaces periodically in Central and West Africa, and there is an active outbreak right now in the DRC and Uganda. Infection requires direct contact with the bodily fluids of a symptomatic person or an infected animal, so the risk for people outside affected regions is very low but not theoretically zero.

Ebola is not well-suited to pandemic spread, it is not airborne, and it requires close contact with infectious bodily fluids, which limits its ability to move the way a respiratory virus does. Every major outbreak so far has been contained. That said, cross-border spread to Uganda and the PHEIC declaration show why vigilance and rapid international response are non-negotiable right now.

It is possible for individual imported cases to occur, it happened in 2014 when a traveller from West Africa brought Ebola to Dallas. What is extremely unlikely is sustained community transmission in a country with robust infection-control infrastructure. The CDC and public health authorities maintain surveillance protocols specifically to detect and contain any such importation.

No. Ebola's case fatality rate varies by outbreak and strain, it has ranged historically from roughly 25% to 90%, depending on the virus variant and the quality of care available. Improved supportive care and, more recently, approved treatments have pushed survival rates significantly higher than they were in early outbreaks.

The very first documented Ebola patient, the index case in the 1976 outbreaks, was a schoolteacher in Yambuku, DRC (then Zaire), though historical research has also pointed to earlier, undetected cases. 'Patient Zero' for any specific outbreak is identified through contact-tracing after the fact, and the index case for the current 2026 outbreak has not been publicly confirmed in verified reporting.

Not a domestic outbreak in the traditional sense, but the US did have a serious scare in 2014 when Thomas Eric Duncan, who had travelled from Liberia, was diagnosed in Dallas and died there. Two nurses who cared for him were also infected but survived. That episode exposed gaps in hospital preparedness and led to major protocol overhauls.

No confirmed cases of Ebola in the US have been reported as part of the current 2026 outbreak, based on available verified information. The CDC actively monitors for any potential imported cases and coordinates with international health authorities; check CDC.gov for the most current status.

No animal is definitively 'immune,' but fruit bats, particularly species in the genus Rousettus and related families, are widely regarded as the most likely natural reservoir of Ebola viruses, meaning they can carry and spread the virus without appearing to get sick. The exact mechanisms of their tolerance are still an active area of scientific research.

Two monoclonal antibody treatments, Inmazeb (atoltivimab/maftivimab/odesivimab) and Ebanga (ansuvimab), were approved by the US FDA and have shown strong efficacy against the Zaire strain of Ebola, dramatically improving survival odds when administered early. They are not a guarantee, and their effectiveness against all strains (including Bundibugyo, which is present in the current Uganda cases) varies, but calling Ebola an automatic death sentence is no longer accurate.

Yes. During the 2014–2016 West Africa epidemic, a small number of cases were diagnosed on US soil, most notably the Dallas case involving a Liberian traveller, and a few healthcare workers who contracted the virus abroad and were medically evacuated for treatment. There was no sustained US outbreak.

The Democratic Republic of the Congo has experienced more Ebola outbreaks than any other country, over a dozen since the virus was first identified in 1976 on the banks of the Ebola River within its borders. The current 2026 outbreak, centred in Ituri province, is the latest and one of the largest chapters in that grim history.

Yes, very much so. Ebola is endemic to Central and West Africa, with outbreaks recurring in the DRC, Uganda, Guinea, and other countries over the decades. The current 2026 crisis, with hundreds of confirmed cases and a WHO emergency declaration, is the clearest possible proof that Ebola never stopped being a real and active threat.

The 2013–2016 West Africa epidemic, centred on Guinea, Sierra Leone, and Liberia, is by far the largest and deadliest Ebola outbreak on record, with over 28,000 cases and more than 11,000 deaths. The current 2026 outbreak in DRC and Uganda is described as among the largest since the virus was identified, but has not yet approached those catastrophic numbers.

No, not categorically. The development of approved monoclonal antibody therapies has significantly improved survival rates, particularly for the Zaire strain. That said, outcomes still depend heavily on how quickly treatment begins and what quality of healthcare is accessible, in remote or under-resourced areas, Ebola remains extremely dangerous and often fatal.

Historically, index cases of Ebola outbreaks are believed to have acquired the virus through contact with infected animals, most likely fruit bats or animals that had themselves been exposed to bats. The specific route of infection for the index case of the 2026 outbreak has not been publicly confirmed in verified reporting, and public health investigators typically determine this through retrospective contact tracing.

There are approved treatments, specifically two monoclonal antibody therapies (Inmazeb and Ebanga), that have proven highly effective against the Zaire Ebola strain when given early, and a preventive vaccine (rVSV-ZEBOV, marketed as Ervebo) is also available. These are not universal cures for all Ebola virus species, but they represent a genuine scientific breakthrough compared to the situation a decade ago.

Liberia suffered the highest death toll during the 2013–2016 West Africa epidemic, losing over 4,800 people, a devastating blow for a small country still recovering from civil war. In terms of total historical outbreak frequency, the Democratic Republic of the Congo holds the grim record, and it is the epicentre of the current 2026 emergency.

Yes, Ebola viruses persist in animal reservoirs in nature and are not eradicable the way smallpox was. The current 2026 outbreak in DRC and Uganda is live proof of that. Between outbreaks the virus is not gone; it is simply circulating in wildlife, waiting for the next spillover event into humans.